| scholarly article | Q13442814 |
| P50 | author | Zhiren Zhang | Q56027888 |
| P2093 | author name string | M Jiang | |
| Y Liu | |||
| X Yang | |||
| H Chen | |||
| Y Wu | |||
| J Xiong | |||
| L Qiu | |||
| R Shi | |||
| B Luo | |||
| P2860 | cites work | Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice | Q24669591 |
| Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice | Q28345267 | ||
| Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function | Q28505705 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| Regulation of wound healing by growth factors and cytokines | Q29615242 | ||
| Cutaneous wound healing | Q29618894 | ||
| Human skin wounds: a major and snowballing threat to public health and the economy | Q30227432 | ||
| Peroxisome proliferator-activated receptors: from genes to physiology | Q32120242 | ||
| Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice | Q33537990 | ||
| The phenotype of murine wound macrophages | Q33571172 | ||
| Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency | Q33683897 | ||
| Age-related alterations in the inflammatory response to dermal injury | Q34102040 | ||
| Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation | Q34116215 | ||
| Dermal wound healing is subject to redox control | Q34425336 | ||
| Advances in wound care and healing technology | Q34434007 | ||
| Inflammatory cells during wound repair: the good, the bad and the ugly | Q34456471 | ||
| Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement | Q34649313 | ||
| Upregulation of ski in fibroblast is implicated in the peroxisome proliferator--activated receptor δ-mediated wound healing. | Q51536341 | ||
| Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. | Q52103301 | ||
| Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils. | Q52767124 | ||
| Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. | Q53608183 | ||
| Macrophage phagocytosis of wound neutrophils. | Q54109057 | ||
| PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. | Q54439080 | ||
| Differential roles of macrophages in diverse phases of skin repair. | Q54440277 | ||
| The Local Effects of Cachectin/Tumor Necrosis Factor on Wound Healing | Q67696849 | ||
| Tumor necrosis factor alpha inhibits wound healing in the rat | Q67875627 | ||
| Editorial: macrophage functional phenotypes: no alternatives in dermal wound healing? | Q82390208 | ||
| The characteristic expression of B7-associated proteins in Langerhans cell sarcoma | Q83392180 | ||
| Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? | Q35178526 | ||
| Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing | Q35641318 | ||
| Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. | Q35691580 | ||
| Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study | Q35740906 | ||
| Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing | Q35779604 | ||
| Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones | Q35794061 | ||
| Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils | Q36141195 | ||
| Proresolution therapy for the treatment of delayed healing of diabetic wounds. | Q36560613 | ||
| Inflammation and wound healing: the role of the macrophage | Q36679987 | ||
| Pathophysiology of acute wound healing | Q36727365 | ||
| Clearance of apoptotic cells by phagocytes | Q36850155 | ||
| Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma | Q37071874 | ||
| Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. | Q37103503 | ||
| Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 | Q37116947 | ||
| Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines | Q37185721 | ||
| The liaison between apoptotic cells and macrophages--the end programs the beginning. | Q37427782 | ||
| Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression | Q37452288 | ||
| Selective and specific macrophage ablation is detrimental to wound healing in mice | Q37462741 | ||
| Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. | Q37470344 | ||
| Apoptotic cell: linkage of inflammation and wound healing. | Q37497691 | ||
| Molecular microbiology: new dimensions for cutaneous biology and wound healing | Q37559264 | ||
| Skin wound healing modulation by macrophages | Q37787051 | ||
| Macrophages in skin injury and repair | Q37833809 | ||
| Modulation of macrophage phenotype by soluble product(s) released from neutrophils. | Q40460717 | ||
| Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma | Q40883227 | ||
| Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). | Q41776430 | ||
| TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing | Q42513753 | ||
| An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice | Q42652064 | ||
| Abnormal cell responses and role of TNF-α in impaired diabetic wound healing | Q43240676 | ||
| Arginine metabolism in wounds | Q43968290 | ||
| Ca2+ release from sarcoplasmic reticulum of skinned fast- and slow-twitch muscle fibers | Q44052217 | ||
| Subcutaneous sponge models | Q44490571 | ||
| Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages | Q44620791 | ||
| Wound fluid inhibits wound fibroblast nitric oxide synthesis | Q45136040 | ||
| PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis | Q45285303 | ||
| PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation | Q47574930 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | macrophage | Q184204 |
| wound healing | Q1509074 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | e1597 | |
| P577 | publication date | 2015-01-15 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Macrophage peroxisome proliferator-activated receptor γ deficiency delays skin wound healing through impairing apoptotic cell clearance in mice | |
| P478 | volume | 6 |
| Q90293980 | A Sterol from Soft Coral Induces Apoptosis and Autophagy in MCF-7 Breast Cancer Cells |
| Q50177254 | Development and validation of the experimental wound assessment tool (EWAT) for pressure ulcer in laboratory animals. |
| Q40961297 | Development of Novel Mouse Model of Ulcers Induced by Implantation of Magnets |
| Q36805643 | Diabetes medications: Impact on inflammation and wound healing |
| Q41902511 | Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2? |
| Q97526755 | Macrophage Dysregulation and Impaired Skin Wound Healing in Diabetes |
| Q35875469 | Macrophage PPARγ and impaired wound healing in type 2 diabetes |
| Q90133812 | Macrophage mediation in normal and diabetic wound healing responses |
| Q55085773 | Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids. |
| Q47739408 | Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair |
| Q37089046 | Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. |
| Q53175949 | Roles of Macrophage Subtypes in Bowel Anastomotic Healing and Anastomotic Leakage. |
| Q90242473 | Targeting metabolic dysregulation for fibrosis therapy |
| Q38649395 | Transcriptional control of microglia phenotypes in health and disease. |
Search more.